Opus Genetics, Inc. (IRD) — Cash Flow Quality Index
Opus Genetics, Inc. (IRD) has a Cash Flow Quality Index of -0.54x as of September 2023. Operating cash flow of $-3.00 Million is below net income of $5.56 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Opus Genetics, Inc. (IRD) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Opus Genetics, Inc. Cash Flow Quality Index (2022–2022)
Historical Cash Flow Quality Index for Opus Genetics, Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Opus Genetics, Inc. total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Opus Genetics, Inc. (2022–2022)
Year-by-year earnings quality comparison for Opus Genetics, Inc.. For live market cap and the full company financial profile, see Opus Genetics, Inc. (IRD) total market value.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 0.80x | $14.31 Million | $17.89 Million | — |